| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.7K | $12.84M | - | |
| CEO | 80.5K | $5.85M | - | |
| Dir | 80.0K | $5.81M | - | |
| Dir | 59.6K | $4.33M | - | |
| Pres | 25.0K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2017 | Roger C Lucas | Director | Sell | 100 | $101.15 | $10,115.20 | -2.7% | |
| Mar 10, 2017 | Roger C Lucas | Director | Sell | 100 | $107.77 | $10,777.05 | -2.7% | |
| Feb 10, 2017 | Roger C Lucas | Director | Sell | 100 | $102.60 | $10,260.00 | -2.6% | |
| Jan 10, 2017 | Roger C Lucas | Director | Sell | 100 | $103.57 | $10,357.00 | -2.5% | |
| Dec 9, 2016 | Roger C Lucas | Director | Sell | 100 | $108.92 | $10,892.48 | -2.5% | |
| Nov 29, 2016 | Karen A Holbrook | Director | Sell | 1,000 | $106.73 | $106,733.00 | -33.6% | |
| Nov 16, 2016 | Roger C Lucas | Director | Sell | 100 | $105.75 | $10,575.00 | -2.4% | |
| Oct 19, 2016 | Roger C Lucas | Director | Sell | 100 | $104.71 | $10,471.00 | -3.0% | |
| Sep 21, 2016 | Roger C Lucas | Director | Sell | 100 | $108.91 | $10,891.00 | -2.9% | |
| Sep 8, 2016 | Kevin S Gould | SVP Clinical Controls | Sell | 524 | $110.50 | $57,903.57 | -23.9% |